These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 8113344)

  • 1. The use of African horse sickness virus VP7 antigen, synthesised in bacteria, and anti-VP7 monoclonal antibodies in a competitive ELISA.
    Wade-Evans AM; Woolhouse T; O'Hara R; Hamblin C
    J Virol Methods; 1993 Dec; 45(2):179-88. PubMed ID: 8113344
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preparation of recombinant African horse sickness virus VP7 antigen via a simple method and validation of a VP7-based indirect ELISA for the detection of group-specific IgG antibodies in horse sera.
    Maree S; Paweska JT
    J Virol Methods; 2005 Apr; 125(1):55-65. PubMed ID: 15737417
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of competitive ELISA for serodiagnosis on African horsesickness virus using baculovirus expressed VP7 and monoclonal antibody.
    Kweon CH; Kwon BJ; Ko YJ; Kenichi S
    J Virol Methods; 2003 Oct; 113(1):13-8. PubMed ID: 14500122
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Baculovirus expression of non-structural protein NS2 and core protein VP7 of African horsesickness virus serotype 3 and their use as antigens in an indirect ELISA.
    Bremer CW; du Plessis DH; van Dijk AA
    J Virol Methods; 1994 Jul; 48(2-3):245-56. PubMed ID: 7989441
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The use of African horse sickness virus NS3 protein, expressed in bacteria, as a marker to differentiate infected from vaccinated horses.
    Laviada MD; Roy P; Sánchez-Vizcaíno JM; Casal JI
    Virus Res; 1995 Oct; 38(2-3):205-18. PubMed ID: 8578859
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Production of monoclonal antibodies binding to the VP7 protein of African horse sickness virus.
    Luciani M; Armillotta G; Ciarelli A; Ulisse S; Teodori L; Bortone G; Giamboi A; Monaco F; Tittarelli M; Di Ventura M; Iannetti L; Podaliri Vulpiani M; Di Febo T
    J Virol Methods; 2019 Aug; 270():131-136. PubMed ID: 31095974
    [TBL] [Abstract][Full Text] [Related]  

  • 7. African horse sickness virus serotype 4 antigens, VP1-1, VP2-2, VP4, VP7 and NS3, induce cytotoxic T cell responses in vitro.
    Faber FE; van Kleef M; Tshilwane SI; Pretorius A
    Virus Res; 2016 Jul; 220():12-20. PubMed ID: 27063332
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Detection of African horsesickness virus in infected spleens by a sandwich ELISA using two monoclonal antibodies specific for VP7.
    Laviada MD; Babín M; Dominguez J; Sánchez-Vizcaíno JM
    J Virol Methods; 1992 Aug; 38(2):229-42. PubMed ID: 1517353
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Full protection against African horsesickness (AHS) in horses induced by baculovirus-derived AHS virus serotype 4 VP2, VP5 and VP7.
    Martínez-Torrecuadrada JL; Díaz-Laviada M; Roy P; Sánchez C; Vela C; Sánchez-Vizcaíno JM; Casal JI
    J Gen Virol; 1996 Jun; 77 ( Pt 6)():1211-21. PubMed ID: 8683209
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnostic DIVA tests accompanying the Disabled Infectious Single Animal (DISA) vaccine platform for African horse sickness.
    van Rijn PA; Maris-Veldhuis MA; Boonstra J; van Gennip RGP
    Vaccine; 2018 Jun; 36(25):3584-3592. PubMed ID: 29759377
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cloning, characterization and expression of the gene that encodes the major neutralization-specific antigen of African horsesickness virus serotype 3.
    Vreede FT; Huismans H
    J Gen Virol; 1994 Dec; 75 ( Pt 12)():3629-33. PubMed ID: 7996157
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diagnostic methods for African horsesickness virus using monoclonal antibodies to structural and non-structural proteins.
    Ranz AI; Miguet JG; Anaya C; Venteo A; Cortés E; Vela C; Sanz A
    Vet Microbiol; 1992 Nov; 33(1-4):143-53. PubMed ID: 1481354
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of reverse transcriptase-polymerase chain reaction (RT-PCR) and dot-blot hybridisation for the detection and identification of African horse sickness virus nucleic acids.
    Zientara S; Sailleau C; Moulay S; Crucière C; el-Harrak M; Laegreid WW; Hamblin C
    Arch Virol Suppl; 1998; 14():317-27. PubMed ID: 9785517
    [TBL] [Abstract][Full Text] [Related]  

  • 14. African horsesickness virus VP7 sub-unit vaccine protects mice against a lethal, heterologous serotype challenge.
    Wade-Evans AM; Pullen L; Hamblin C; O'Hara R; Burroughs JN; Mertens PP
    J Gen Virol; 1997 Jul; 78 ( Pt 7)():1611-6. PubMed ID: 9225037
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intracellular production of African horsesickness virus core-like particles by expression of the two major core proteins, VP3 and VP7, in insect cells.
    Maree S; Durbach S; Huismans H
    J Gen Virol; 1998 Feb; 79 ( Pt 2)():333-7. PubMed ID: 9472617
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A blocking ELISA for detection of antibody to a subgroup-reactive epitope of African horsesickness viral protein 7 (VP7) using a novel gamma-irradiated antigen.
    House JA; Stott JL; Blanchard MT; LaRocco M; Llewellyn ME
    Ann N Y Acad Sci; 1996 Jul; 791():333-44. PubMed ID: 8784514
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serologic markers in early stages of African horse sickness virus infection.
    Martínez-Torrecuadrada JL; Díaz-Laviada M; Roy P; Sánchez C; Vela C; Sánchez-Vizcaíno JM; Casal JI
    J Clin Microbiol; 1997 Feb; 35(2):531-5. PubMed ID: 9003637
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The complete sequence of four major structural proteins of African horse sickness virus serotype 6: evolutionary relationships within and between the orbiviruses.
    Williams CF; Inoue T; Lucus AM; Zanotto PM; Roy P
    Virus Res; 1998 Jan; 53(1):53-73. PubMed ID: 9617769
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vaccination with recombinant Modified Vaccinia Ankara (MVA) viruses expressing single African horse sickness virus VP2 antigens induced cross-reactive virus neutralising antibodies (VNAb) in horses when administered in combination.
    Manning NM; Bachanek-Bankowska K; Mertens PPC; Castillo-Olivares J
    Vaccine; 2017 Oct; 35(44):6024-6029. PubMed ID: 28438410
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Validation of ELISA for the detection of African horse sickness virus antigens and antibodies.
    Rubio C; Cubillo MA; Hooghuis H; Sanchez-Vizcaino JM; Diaz-Laviada M; Plateau E; Zientara S; Crucière C; Hamblin C
    Arch Virol Suppl; 1998; 14():311-5. PubMed ID: 9785516
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.